West James Lee, Lewis Clifton, Still Sasha, Eudailey Kyle
Division of Cardiothoracic Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama.
Ann Thorac Surg Short Rep. 2023 Nov 23;2(1):1-5. doi: 10.1016/j.atssr.2023.11.007. eCollection 2024 Mar.
Jehovah's Witnesses are known to refuse allogeneic blood products. Consequently, many surgeons will decline to perform aortic surgery on this patient group, given their higher risk. We present here a case series describing operative repair of type A aortic dissection without the use of allogeneic blood products.
From 2018 to 2021, 6 Jehovah's Witness patients underwent open repair of type A aortic dissection. We reviewed preoperative characteristics, diagnostic workup, operative technique, and postoperative outcomes. We also looked specifically at use of autologous whole blood, Cell Saver (Haemonetics) transfusion, synthetic clotting factors (recombinant factor VIIa), and albumin and prothrombin complex concentrate when allowed.
Modified hemiarch replacement was performed with the branched single-anastomosis frozen elephant trunk repair (B-SAFER) technique in 4 patients; 2 patients received a standard hemiarch replacement. Aortic valve replacement was performed in 2 patients; root replacement was performed in 1 patient. There were no immediate postoperative coronary complications, strokes, or instances of renal failure. Average decrease in hemoglobin concentration after surgery was 2.3 ± 1.5 g/dL (mean ± SD). Thirty-day mortality was 0. Five of 6 patients survived to discharge, and all survivors to discharge were still alive at the time of submission.
Bloodless aortic dissection repair in these rare patients can be performed safely in specialized centers using the techniques described. Furthermore, we believe that these techniques can be applied to the general population of patients undergoing emergent cardiac operation to avoid allogeneic transfusions.
已知耶和华见证会成员拒绝接受异体血制品。因此,鉴于风险较高,许多外科医生会拒绝为该患者群体进行主动脉手术。我们在此展示一系列病例,描述在不使用异体血制品的情况下对A型主动脉夹层进行手术修复。
2018年至2021年,6名耶和华见证会患者接受了A型主动脉夹层的开放修复手术。我们回顾了术前特征、诊断检查、手术技术和术后结果。我们还特别关注自体全血的使用、细胞回收机(Haemonetics)输血、合成凝血因子(重组凝血因子VIIa)以及在允许情况下白蛋白和凝血酶原复合物浓缩物的使用。
4例患者采用分支单吻合口冷冻象鼻修复术(B-SAFER)进行改良半弓置换;2例患者接受标准半弓置换。2例患者进行了主动脉瓣置换;1例患者进行了根部置换。术后无立即发生的冠状动脉并发症、中风或肾衰竭病例。术后血红蛋白浓度平均下降2.3±1.5g/dL(均值±标准差)。30天死亡率为0。6例患者中有5例存活至出院,提交报告时所有存活出院的患者仍在世。
在专门的中心使用所述技术,可以安全地为这些罕见患者进行无血主动脉夹层修复。此外,我们认为这些技术可应用于接受紧急心脏手术的普通患者群体,以避免异体输血。